140 related articles for article (PubMed ID: 37835455)
21. [Retrospective study of thyroid invasion and central lymph node metastasis in 124 patients with hypopharyngeal carcinoma].
Liu HF; Huang ZG; Fang JG; Chen XH; Zhang Y; Hou LZ; Ma HZ; Guo W; Zhong Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Sep; 56(9):956-961. PubMed ID: 34666444
[No Abstract] [Full Text] [Related]
22. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
Rajoria S; Suriano R; George A; Shanmugam A; Schantz SP; Geliebter J; Tiwari RK
PLoS One; 2011 Jan; 6(1):e15879. PubMed ID: 21267453
[TBL] [Abstract][Full Text] [Related]
23. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
24. Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.
Bai Q; Pan Z; Nabi G; Rashid F; Liu Y; Khan S
Am J Cancer Res; 2022; 12(3):961-973. PubMed ID: 35411240
[TBL] [Abstract][Full Text] [Related]
25. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
Zhang P; Wang C; Ma T; You S
Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
[TBL] [Abstract][Full Text] [Related]
26. LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5.
Yuan J; Song Y; Pan W; Li Y; Xu Y; Xie M; Shen Y; Zhang N; Liu J; Hua H; Wang B; An C; Yang M
Oncogene; 2020 Oct; 39(43):6664-6676. PubMed ID: 32939012
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.
Das S; Babu A; Medha T; Ramanathan G; Mukherjee AG; Wanjari UR; Murali R; Kannampuzha S; Gopalakrishnan AV; Renu K; Sinha D; George Priya Doss C
Med Oncol; 2023 Apr; 40(5):149. PubMed ID: 37060468
[TBL] [Abstract][Full Text] [Related]
28. Update on thyroid cancer treatment.
Regalbuto C; Frasca F; Pellegriti G; Malandrino P; Marturano I; Di Carlo I; Pezzino V
Future Oncol; 2012 Oct; 8(10):1331-48. PubMed ID: 23130931
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma.
Shi D; Wang H; Ding M; Yang M; Li C; Yang W; Chen L
Onco Targets Ther; 2019; 12():6605-6616. PubMed ID: 31496749
[TBL] [Abstract][Full Text] [Related]
30.
Sasaki N; Toyoda M; Yoshimura H; Matsuda Y; Arai T; Takubo K; Aida J; Ishiwata T
Oncotarget; 2018 Oct; 9(78):34719-34734. PubMed ID: 30410672
[TBL] [Abstract][Full Text] [Related]
31. Long Non-coding RNA RUNDC3A-AS1 Promotes Lung Metastasis of Thyroid Cancer via Targeting the miR-182-5p/ADAM9.
Ma D; Zhu Y; Zhang X; Zhang J; Chen W; Chen X; Qian Y; Zhao Y; Hu T; Yao Z; Zhao W; Zhang Y; Liu F
Front Cell Dev Biol; 2021; 9():650004. PubMed ID: 34046406
[TBL] [Abstract][Full Text] [Related]
32. SASH1 inhibits proliferation and invasion of thyroid cancer cells through PI3K/Akt signaling pathway.
Sun D; Zhou R; Liu H; Sun W; Dong A; Zhang H
Int J Clin Exp Pathol; 2015; 8(10):12276-83. PubMed ID: 26722413
[TBL] [Abstract][Full Text] [Related]
33. Overcoming drug resistance and treating advanced prostate cancer.
Semenas J; Allegrucci C; Boorjian SA; Mongan NP; Persson JL
Curr Drug Targets; 2012 Sep; 13(10):1308-23. PubMed ID: 22746994
[TBL] [Abstract][Full Text] [Related]
34. Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p.
Xia F; Chen Y; Jiang B; Bai N; Li X
Cancer Cell Int; 2020; 20():49. PubMed ID: 32082079
[TBL] [Abstract][Full Text] [Related]
35. Targeting invadopodia for blocking breast cancer metastasis.
Meirson T; Gil-Henn H
Drug Resist Updat; 2018 Jul; 39():1-17. PubMed ID: 30075834
[TBL] [Abstract][Full Text] [Related]
36. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
37. Examining the relationship between cancer invasion/metastasis and drug resistance.
Liang Y; McDonnell S; Clynes M
Curr Cancer Drug Targets; 2002 Sep; 2(3):257-77. PubMed ID: 12188911
[TBL] [Abstract][Full Text] [Related]
38. PDZK1IP1 gene promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Zhang W; Zheng D; Jin L; Hirachan S; Bhandari A; Li Y; Chen B; Lu Y; Wen J; Lin B; Zhang X; Chen C
Pathol Res Pract; 2022 Oct; 238():154091. PubMed ID: 36057192
[TBL] [Abstract][Full Text] [Related]
39. High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy.
Fiorillo M; Ózsvári B; Sotgia F; Lisanti MP
Front Oncol; 2021; 11():740720. PubMed ID: 34722292
[TBL] [Abstract][Full Text] [Related]
40. Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer.
Liu T; Men Q; Su X; Chen W; Zou L; Li Q; Song M; Ouyang D; Chen Y; Li Z; Fu X; Yang A
Oncol Lett; 2017 Dec; 14(6):7506-7512. PubMed ID: 29344196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
